Li Y - Search Results

1

High-performance gene expression and knockout tools using sleeping beauty transposon system.

Hu K, Li Y, Wu W, Chen H, Chen Z, Zhang Y, Guo Y, Dong Y. Hu K, et al. Among authors: li y. Mob DNA. 2018 Nov 26;9:33. doi: 10.1186/s13100-018-0139-y. eCollection 2018. Mob DNA. 2018. PMID: 30534207 Free PMC article.

2

Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.

Yan H, Hu K, Wu W, Li Y, Tian H, Chu Z, Koeffler HP, Yin D. Yan H, et al. Among authors: li y. PLoS One. 2016 Aug 17;11(8):e0159954. doi: 10.1371/journal.pone.0159954. eCollection 2016. PLoS One. 2016. PMID: 27532268 Free PMC article.

3

FBW7 suppresses cell proliferation and G2/M cell cycle transition via promoting γ-catenin K63-linked ubiquitylation.

Li Y, Hu K, Xiao X, Wu W, Yan H, Chen H, Chen Z, Yin D. Li Y, et al. Biochem Biophys Res Commun. 2018 Mar 4;497(2):473-479. doi: 10.1016/j.bbrc.2018.01.192. Epub 2018 Feb 2. Biochem Biophys Res Commun. 2018. PMID: 29408378

4

Correction to: High-performance gene expression and knockout tools using sleeping beauty transposon system.

Hu K, Li Y, Wu W, Chen H, Chen Z, Zhang Y, Guo Y, Yin D. Hu K, et al. Among authors: li y. Mob DNA. 2019 Jan 9;10:2. doi: 10.1186/s13100-019-0145-8. eCollection 2019. Mob DNA. 2019. PMID: 30636978 Free PMC article.

5

Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.

Hu K, Wu W, Li Y, Lin L, Chen D, Yan H, Xiao X, Chen H, Chen Z, Zhang Y, Xu S, Guo Y, Koeffler HP, Song E, Yin D. Hu K, et al. Among authors: li y. EMBO Rep. 2019 May;20(5):e46166. doi: 10.15252/embr.201846166. Epub 2019 Apr 2. EMBO Rep. 2019. PMID: 30940648 Free PMC article.

6

RCC2 promotes breast cancer progression through regulation of Wnt signaling and inducing EMT.

Chen Z, Wu W, Huang Y, Xie L, Li Y, Chen H, Li W, Yin D, Hu K. Chen Z, et al. Among authors: li y, li w. J Cancer. 2019 Nov 1;10(27):6837-6847. doi: 10.7150/jca.36430. eCollection 2019. J Cancer. 2019. PMID: 31839818 Free PMC article.

7

Transcription factor NFYA promotes G1/S cell cycle transition and cell proliferation by transactivating cyclin D1 and CDK4 in clear cell renal cell carcinoma.

Li Y, Xiao X, Chen H, Chen Z, Hu K, Yin D. Li Y, et al. Am J Cancer Res. 2020 Aug 1;10(8):2446-2463. eCollection 2020. Am J Cancer Res. 2020. PMID: 32905496 Free PMC article.

8

PARK2 promotes mitochondrial pathway of apoptosis and antimicrotubule drugs chemosensitivity via degradation of phospho-BCL-2.

Chen H, Li Y, Li Y, Chen Z, Xie L, Li W, Zhu Y, Xue H, Koeffler HP, Wu W, Hu K, Yin D. Chen H, et al. Among authors: li y, li w. Theranostics. 2020 Aug 8;10(22):9984-10000. doi: 10.7150/thno.47044. eCollection 2020. Theranostics. 2020. PMID: 32929329 Free PMC article.

9

ATM-Dependent Recruitment of BRD7 is required for Transcriptional Repression and DNA Repair at DNA Breaks Flanking Transcriptional Active Regions.

Hu K, Li Y, Wu W, Xie L, Yan H, Cai Y, Chen D, Jiang Q, Lin L, Chen Z, Liao JY, Zhang Y, Koeffler HP, Yin D, Song E. Hu K, et al. Among authors: li y. Adv Sci (Weinh). 2020 Sep 3;7(20):2000157. doi: 10.1002/advs.202000157. eCollection 2020 Oct. Adv Sci (Weinh). 2020. PMID: 33101843 Free PMC article.

10

SUMOylation of RNF146 results in Axin degradation and activation of Wnt/β-catenin signaling to promote the progression of hepatocellular carcinoma.

Li W, Han Q, Zhu Y, Zhou Y, Zhang J, Wu W, Li Y, Liu L, Qiu Y, Hu K, Yin D. Li W, et al. Among authors: li y. Oncogene. 2023 May;42(21):1728-1740. doi: 10.1038/s41388-023-02689-4. Epub 2023 Apr 7. Oncogene. 2023. PMID: 37029301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240,199 results

Search Page

Filters